Regenerative and stem cell therapy practices part 21

Stem cell 2

 

Regulation in the regenerative and stem cell therapy arena is continuing to evolve. Human cells, tissues, and cellular or tissue-based products are currently regulated under Sections 351 and 361 of the Publich Health Service Act. However, a human cells, tissues, and cellular or tissue-based products can be regulated solely under Section 361 of the Public Health Service Act if it is:

  1. Minimally manipulated
  2. Intended for homologous use only
  3. Not combined with another article, and
  4. Either:
  • Does not have a systemic effect and is not dependent upon the metabolic activity of living cells for its primary function; or
  • Has a systemic effect or is dependent upon the metabolic activity of living cells for its primary function, and is for autologous use, use in a first or second-degree blood relative, or reproductive use

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s